Axonal cholinergic binding macromolecule. Response to neuroactive drugs.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001370:Axonal Transport / Q000187:drug effects; D001369:Axons / Q000187:drug effects / Q000502:physiology*; D001665:Binding Sites; D001667:Binding, Competitive; D003634:DDT / Q000494:pharmacology; D006426:Hemicholinium 3 / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D008024:Ligands / Q000378:metabolism; D046911:Macromolecular Substances; D008121:Nephropidae; D009538:Nicotine / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010634:Phenobarbital / Q000494:pharmacology; D011343:Procaine / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects; D013757:Tetraethylammonium Compounds / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology; D014118:Toxins, Biological / Q000494:pharmacology; D014316:Tritium; D014702:Veratrine / Q000494:pharmacology
D007093:Imidazoles; D008024:Ligands; D046911:Macromolecular Substances; D010276:Parasympatholytics; D011950:Receptors, Cholinergic; D013757:Tetraethylammonium Compounds; D014118:Toxins, Biological; D014316:Tritium; D006426:Hemicholinium 3; D013779:Tetrodotoxin; D011343:Procaine; D010042:Ouabain; D009538:Nicotine; D003634:DDT; D014702:Veratrine; D010634:Phenobarbital